Want to see KR:101140 full AI Analyst Report?
INBIOGEN CO., Ltd. (101140) Income Statement
INBIOGEN CO., Ltd. Income Statement
Last quarter (Q2 2026), INBIOGEN CO., Ltd.'s total revenue was ₩1.51B, a decrease of 18.39% from the same quarter last year. In Q2, INBIOGEN CO., Ltd.'s net income was ₩-1.48B. See INBIOGEN CO., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 6.30B | ₩ 7.04B | ₩ 6.24B | ₩ 11.40B | ₩ 10.48B | |
| ₩ -574.39M | ₩ 660.07M | ₩ 1.28B | ₩ 2.56B | ₩ 1.96B | |
| ₩ 3.76B | ₩ 6.75B | ₩ 7.48B | ₩ 8.50B | ₩ 9.64B | |
| Depreciation and Amortization | ₩ 363.49M | ₩ 1.06B | ₩ 1.22B | ₩ 1.44B | ₩ 1.12B |
| ₩ -3.97B | ₩ 17.23B | ₩ 13.34B | ₩ 45.46B | ₩ 116.01B | |
| ₩ -4.33B | ₩ -6.09B | ₩ -6.15B | ₩ 44.02B | ₩ -7.69B | |
| ₩ 2.91B | ₩ 22.22B | ₩ 25.52B | ₩ -130.60B | ₩ 119.00B | |
| ₩ -1.42B | ₩ 16.12B | ₩ 19.37B | ₩ -136.64B | ₩ 111.06B | |
| ₩ 5.82B | ₩ 16.12B | ₩ 18.86B | ₩ -119.69B | ₩ 94.12B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ 579.79 | ₩ 1614.68 | ₩ 1887.43 | ₩ -33008.46 | ₩ 1753.00 |
| Diluted EPS | ₩ 579.79 | ₩ 1614.68 | ₩ 1887.43 | ₩ -33008.46 | ₩ 1584.00 |
| Weighted Average Shares Outstanding | 10.04M | 9.98M | 9.99M | 3.63M | 2.97M |
| Weighted Average Shares Outstanding (Diluted) | 10.04M | 9.98M | 9.99M | 3.63M | 2.97M |
Currency in KRW
